Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–2 of 2 stories
A new study presents an antibody-oligonucleotide conjugate targeting myotonic dystrophy type 1, potentially offering a novel therapeutic approach. This research could pave the way for innovative treatments for this genetic disorder.
Read full storyA recent study published in PubMed examines minute-by-minute gait variations during the 6-Minute Walk Test in patients with myotonic dystrophy type 1. This research provides insights into the mobility challenges faced by these patients, which could inform future therapeutic approaches.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.